Cargando…
Performance Evaluation of the PowerChek SARS-CoV-2, Influenza A & B Multiplex Real-Time PCR Kit in Comparison with the BioFire Respiratory Panel
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and influenza viruses may pose enormous challenges to our healthcare system. We evaluated the performance of the PowerChek SARS-CoV-2, Influenza A & B Multiplex Real-time PCR Kit (PowerChek; Kogene Biotech, Seoul, Korea) in comparison...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Laboratory Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859561/ https://www.ncbi.nlm.nih.gov/pubmed/35177568 http://dx.doi.org/10.3343/alm.2022.42.4.473 |
_version_ | 1784654488698617856 |
---|---|
author | Kim, Tae Yeul Kim, Ji-Youn Shim, Hyang Jin Yun, Sun Ae Jang, Ja-Hyun Huh, Hee Jae Kim, Jong-Won Lee, Nam Yong |
author_facet | Kim, Tae Yeul Kim, Ji-Youn Shim, Hyang Jin Yun, Sun Ae Jang, Ja-Hyun Huh, Hee Jae Kim, Jong-Won Lee, Nam Yong |
author_sort | Kim, Tae Yeul |
collection | PubMed |
description | Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and influenza viruses may pose enormous challenges to our healthcare system. We evaluated the performance of the PowerChek SARS-CoV-2, Influenza A & B Multiplex Real-time PCR Kit (PowerChek; Kogene Biotech, Seoul, Korea) in comparison with the BioFire Respiratory Panels 2 and 2.1 (RP2 and RP2.1; bioMérieux, Marcy l’Étoile, France), using 147 nasopharyngeal swabs. The limit of detection (LOD) of the PowerChek assay was determined using SARS-CoV-2, influenza A, and B RNA standards. The LOD values of the PowerChek assay for SARS-CoV-2 and influenza A and B were 1.12, 1.24, and 0.61 copies/μL, respectively. The positive and negative percent agreements of the PowerChek assay compared with RP2 and RP2.1 were 97.5% (39/40) and 100% (107/107) for SARS-CoV-2; 100% (39/39) and 100% (108/108) for influenza A; and 100% (35/35) and 100% (112/112) for influenza B, respectively. The performance of the PowerChek assay was comparable to that of RP2 and RP2.1 for detecting SARS-CoV-2 and influenza A and B, suggesting its use in diagnosing SARS-CoV-2 and influenza infections. |
format | Online Article Text |
id | pubmed-8859561 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Korean Society for Laboratory Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-88595612022-07-01 Performance Evaluation of the PowerChek SARS-CoV-2, Influenza A & B Multiplex Real-Time PCR Kit in Comparison with the BioFire Respiratory Panel Kim, Tae Yeul Kim, Ji-Youn Shim, Hyang Jin Yun, Sun Ae Jang, Ja-Hyun Huh, Hee Jae Kim, Jong-Won Lee, Nam Yong Ann Lab Med Brief Communications Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and influenza viruses may pose enormous challenges to our healthcare system. We evaluated the performance of the PowerChek SARS-CoV-2, Influenza A & B Multiplex Real-time PCR Kit (PowerChek; Kogene Biotech, Seoul, Korea) in comparison with the BioFire Respiratory Panels 2 and 2.1 (RP2 and RP2.1; bioMérieux, Marcy l’Étoile, France), using 147 nasopharyngeal swabs. The limit of detection (LOD) of the PowerChek assay was determined using SARS-CoV-2, influenza A, and B RNA standards. The LOD values of the PowerChek assay for SARS-CoV-2 and influenza A and B were 1.12, 1.24, and 0.61 copies/μL, respectively. The positive and negative percent agreements of the PowerChek assay compared with RP2 and RP2.1 were 97.5% (39/40) and 100% (107/107) for SARS-CoV-2; 100% (39/39) and 100% (108/108) for influenza A; and 100% (35/35) and 100% (112/112) for influenza B, respectively. The performance of the PowerChek assay was comparable to that of RP2 and RP2.1 for detecting SARS-CoV-2 and influenza A and B, suggesting its use in diagnosing SARS-CoV-2 and influenza infections. Korean Society for Laboratory Medicine 2022-07-01 2022-07-01 /pmc/articles/PMC8859561/ /pubmed/35177568 http://dx.doi.org/10.3343/alm.2022.42.4.473 Text en © Korean Society for Laboratory Medicine https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Brief Communications Kim, Tae Yeul Kim, Ji-Youn Shim, Hyang Jin Yun, Sun Ae Jang, Ja-Hyun Huh, Hee Jae Kim, Jong-Won Lee, Nam Yong Performance Evaluation of the PowerChek SARS-CoV-2, Influenza A & B Multiplex Real-Time PCR Kit in Comparison with the BioFire Respiratory Panel |
title | Performance Evaluation of the PowerChek SARS-CoV-2, Influenza A & B Multiplex Real-Time PCR Kit in Comparison with the BioFire Respiratory Panel |
title_full | Performance Evaluation of the PowerChek SARS-CoV-2, Influenza A & B Multiplex Real-Time PCR Kit in Comparison with the BioFire Respiratory Panel |
title_fullStr | Performance Evaluation of the PowerChek SARS-CoV-2, Influenza A & B Multiplex Real-Time PCR Kit in Comparison with the BioFire Respiratory Panel |
title_full_unstemmed | Performance Evaluation of the PowerChek SARS-CoV-2, Influenza A & B Multiplex Real-Time PCR Kit in Comparison with the BioFire Respiratory Panel |
title_short | Performance Evaluation of the PowerChek SARS-CoV-2, Influenza A & B Multiplex Real-Time PCR Kit in Comparison with the BioFire Respiratory Panel |
title_sort | performance evaluation of the powerchek sars-cov-2, influenza a & b multiplex real-time pcr kit in comparison with the biofire respiratory panel |
topic | Brief Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859561/ https://www.ncbi.nlm.nih.gov/pubmed/35177568 http://dx.doi.org/10.3343/alm.2022.42.4.473 |
work_keys_str_mv | AT kimtaeyeul performanceevaluationofthepowercheksarscov2influenzaabmultiplexrealtimepcrkitincomparisonwiththebiofirerespiratorypanel AT kimjiyoun performanceevaluationofthepowercheksarscov2influenzaabmultiplexrealtimepcrkitincomparisonwiththebiofirerespiratorypanel AT shimhyangjin performanceevaluationofthepowercheksarscov2influenzaabmultiplexrealtimepcrkitincomparisonwiththebiofirerespiratorypanel AT yunsunae performanceevaluationofthepowercheksarscov2influenzaabmultiplexrealtimepcrkitincomparisonwiththebiofirerespiratorypanel AT jangjahyun performanceevaluationofthepowercheksarscov2influenzaabmultiplexrealtimepcrkitincomparisonwiththebiofirerespiratorypanel AT huhheejae performanceevaluationofthepowercheksarscov2influenzaabmultiplexrealtimepcrkitincomparisonwiththebiofirerespiratorypanel AT kimjongwon performanceevaluationofthepowercheksarscov2influenzaabmultiplexrealtimepcrkitincomparisonwiththebiofirerespiratorypanel AT leenamyong performanceevaluationofthepowercheksarscov2influenzaabmultiplexrealtimepcrkitincomparisonwiththebiofirerespiratorypanel |